Inhalers Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Inhalers Market: By Device Type [Metered Dose Inhaler, Dry Powder Inhaler, Nebulizer (Compressed, Ultrasonic, Mesh)], By Inhaler Type (Preventive, Reliever, Long Acting Bronchodilators), By Application(  Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Cystic Fibrosis), By End User (  Home Care, Hospitals, Clinics), and Geography 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global inhalers market estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 due to technological progressions in the inhalers and rising governments alertness. Moreover, accumulative number of smokers and growing frequency of pulmonary diseases are the major factors driving the growth of the market. Furthermore, increasing pollution across the world, leads to increase in respiratory problems, which propels the growth of the market over the forecast years. Thisreport gives comprehensive outlook on inhalers across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of device type, application, inhaler type, end user, and region. This report studies the dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global  market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global inhalers market report include suppliers, manufacturers, and marketers, policy makers engaged in global inhalers products. Global inhalers market is surging owing to frequent acquisitions, product launch, and collaborations by the market players. For instance, in 2018, the company 3M has introduced an enhanced version of one rescue inhaler in the market.


Inhalers Market

MARKET SUMMARY
-
% CAGR
  • Study Period– 2022– 2028
  • Base Year– 2021
  • CAGR– X%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Inhalers Market

  • Global inhalers market expanding at significant CAGR over 2022 to 2028 owing to launch of newer products into market.
  • Based on device type, metered dose inhaler segment accounted for larger market revenue share in 2021 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global Inhalers market
Market Key Players
  • 3M Company (USA)
  • Aradigm Corporation (California)
  • AstraZeneca Plc. (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • Cipla Inc. (India)
  • GlaxoSmithKline (UK)
Drivers And Restraints

Inhalers Market

Growing pollution through the world, leads to upsurge in respiratory problems, which boosts the growth of the market over the coming years. COPD, asthma, acute lower respiratory tract infections, TB and lung cancer are amongst most communal causes of severe illness and death globally. For example, according WHO, in 2016, around 65 million people have moderate to severe chronic obstructive pulmonary disease (COPD), from which about 3 million die each year, making it the third leading cause of death worldwide.


North-America got significant share

Inhalers Market

North America accounted for larger revenue share in global Inhalers market with significant CAGR owing to increase in prevalence of chronic obstructive pulmonary disease (COPD) over there, increase in research and development for developing new treatment therapies, and improved healthcare facilities. Europe inhalers market accounted for a significant share in global inhalers market. The usage of metered dose inhalers is more popular in European countries leading to the growth of the segment in the region. Asia Pacific inhalers market expected to grow significantly rate due to their emerging economies, increase in the prevalence of COPD, development of healthcare infrastructure, and technological advancements.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Segmentation

Inhalers Market


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • 3M Company (USA)
  • Aradigm Corporation (California)
  • AstraZeneca Plc. (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • Cipla Inc. (India)
  • GlaxoSmithKline (UK)
  • Novartis AG (Switzerland)
  • PULMATRIX, INC. (USA)
  • Teva Respiratory, LLC. (USA)
  • Mankind Corporation (Califonia)
  • BESPAK (UK)
  • Beximo Pharmaceuticals Limited (Bangladesh)
  • Spyryx Biosciences, Inc. (North Carolina)
  • MidasCare Pharmaceuticals Pvt. Ltd. (India)
  • Omega Life Sciences Ltd. (Isreal)
  • Drive DeVilbiss Healthcare Ltd. (UK)
  • Manta Devices LLC. (Cambridge)
  • Savara Inc. (USA)
  • OMRON Healthcare Europe B.V. (Europe)
  • Hovione LLC. (USA)
  • Koninklijke Philips N.V. (Netherlands)
  • Teijin Limited (Japan)
  • Vitalograph Ltd. (UK)

Description

The global inhalers market estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 due to technological progressions in the inhalers and rising governments alertness. Moreover, accumulative number of smokers and growing frequency of pulmonary diseases are the major factors driving the growth of the market. Furthermore, increasing pollution across the world, leads to increase in respiratory problems, which propels the growth of the market over the forecast years. Thisreport gives comprehensive outlook on inhalers across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of device type, application, inhaler type, end user, and region. This report studies the dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global  market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global inhalers market report include suppliers, manufacturers, and marketers, policy makers engaged in global inhalers products. Global inhalers market is surging owing to frequent acquisitions, product launch, and collaborations by the market players. For instance, in 2018, the company 3M has introduced an enhanced version of one rescue inhaler in the market.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX